The Company (Tables)

3 Months Ended

Mar. 31, 2016

The Company [Abstract]

Fair Value Measurements on Recurring Basis

The Company's recurring fair value measurements at March 31, 2016 and December 31, 2015 are as follows:

	Fair Value as of March 31, 2016		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Liabilities:
Warrant liability (Note 10)	$	5,057	$	-	$	-	$	5,057
	Fair Value as of December 31, 2015		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Liabilities:
Warrant liability (Note 10)	$	7,042	$	-	$	-	$	7,042

Accrued Warranty Costs Activity

The activity in the warranty accrual during the three months ended March 31, 2016 is summarized as follows:

	March 31, 2016
	(unaudited)
Accrual at beginning of year	$	226
Additions charged to warranty expense		72
Expiring warranties/claimed satisfied		(119	)
Total		179
Less: current portion		(155	)
	$	24

Diluted Earnings Per Common Share Calculated using Net Loss And Weighted Average Shares Outstanding

Diluted earnings per common share were calculated using the following net loss and weighted average shares outstanding for the three months ended March 31, 2016:

	March 31, 2016
Net loss	$	(1,437	)
Gain on the change in fair value of the warrant liability		(1,985	)
Diluted earnings	$	(3,422	)
Weighted average number of common and common equivalent shares outstanding:
Basic number of common shares outstanding		10,339,657
Dilutive effect of warrants		2,968,266
Diluted number of common and common stock equivalent shares outstanding		13,307,923

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

Potential common stock equivalents outstanding as of March 31, 2016 and 2015 consist of common stock equivalents of common stock purchase warrants, senior secured convertible debentures, convertible preferred stock and common stock options, which are summarized as follows:

		March 31,
	2016		2015
Common stock equivalents of convertible debentures	46,215,126		4,328,466
Common stock purchase warrants	16,729,362		13,078,920
Common stock equivalents of convertible preferred stock	2,535,866		4,007,406
Common stock options	2,669,352		1,293,701
Total	68,149,706		22,708,493